Jan 29, 2021
CannTrust Announces the Issuance of CCAA Representation Order - Appointment of Representative Counsel for the Securities Claimants
Jan 20, 2021
CannTrust Announces Restructuring Support Agreement with Key Class Action Plaintiffs and their Counsel
Jan 08, 2021
CannTrust Announces Launch of New Medical Brand estora(TM)
Dec 02, 2020
CannTrust Returns to the Canadian Marketplace
Sep 16, 2020
CannTrust Postpones Annual General Meeting Date
Sep 10, 2020
CannTrust Applies to Extend Time for Annual General Meeting
Aug 06, 2020
CannTrust Licenses Reinstated for Vaughan Manufacturing Facility
May 29, 2020
CannTrust Receives Notice from Health Canada of License Reinstatement for its Fenwick Facility
May 15, 2020
CannTrust - Sale and Investment Solicitation Process
Apr 14, 2020
Cease Trade Order Issued by Ontario Securities Commission
Apr 09, 2020
CannTrust Provides Default Status Report
Mar 31, 2020
CannTrust Obtains Initial Order under Companies' Creditors Arrangement Act (Canada)
Mar 26, 2020
CannTrust Provides Default Status Report
Mar 23, 2020
CannTrust Provides Update Regarding Health Canada Remediation
Mar 18, 2020
CannTrust Provides Update Regarding TSX Listing
Mar 12, 2020
CannTrust Provides Default Status Report
Feb 28, 2020
CannTrust Receives Continued Listing Notice from the NYSE
Feb 27, 2020
CannTrust Provides Default Status Report
Feb 13, 2020
CannTrust Announces New CEO and Provides Updates on Remediation Plan and New York Stock Exchange Listing
Jan 16, 2020
CannTrust Provides Default Status Report